Data / Drug companies / XGen Pharmaceuticals DJB, Inc.
XGen Pharmaceuticals DJB, Inc.: 31 products in the FDA NDC directory, labeler code 39822
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
XGen Pharmaceuticals DJB, Inc. (labeler code 39822) lists 31 products in the FDA National Drug Code Directory, covering 23 finished drugs by generic name. By type: 31 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on April 7, 2026.
The request: Watch XGen Pharmaceuticals DJB, Inc. (FDA labeler code 39822): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 39822
- Products in commercial distribution
- 31
- Packages
- 34
- Finished drugs by generic name
- 23
- Prescription products
- 31
- Over the counter products
- 0
- Flagged as original packager
- 27 of 27 products that carry the flag
- Started marketing in the last 12 months
- 3
- Earliest marketing start
- April 29, 1992
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 31 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 31 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Cyclophosphamide | 3 | 22 |
| Vancomycin hydrochloride | 2 | 39 |
| Desmopressin acetate | 2 | 27 |
| Neomycin and polymyxin b sulfates | 2 | 1 |
| Lincomycin hydrochloride | 2 | 6 |
| Promethazine hydrochloride | 2 | 49 |
| Clonidine | 2 | 9 |
| Levetiracetam | 1 | 87 |
| Liothyronine sodium | 1 | 19 |
| Eribulin mesylate | 1 | 17 |
| Dactinomycin | 1 | 4 |
| Pentamidine isethionate | 1 | 5 |
| Tranexamic acid | 1 | 39 |
| Tobramycin | 1 | 41 |
| Amphotericin b | 1 | 4 |
| Rocuronium bromide | 1 | 25 |
| Streptomycin | 1 | 1 |
| Olanzapine | 1 | 49 |
| Acetazolamide | 1 | 37 |
| Nelarabine | 1 | 13 |
| Alcohol | 1 | 293 |
| Ibuprofen lysine | 1 | 3 |
| Folic acid | 1 | 34 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 12 | 38.7% |
| Injection, powder, lyophilized, for solution | 10 | 32.3% |
| Solution | 4 | 12.9% |
| Injection | 2 | 6.5% |
| Injection, solution, concentrate | 1 | 3.2% |
| Inhalant | 1 | 3.2% |
| Injection, powder, for solution | 1 | 3.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Eribulin mesylate | 39822-2080 | Injection | Generic drugs (ANDA) | April 7, 2026 |
| Vancomycin Hydrochloride | 39822-0470 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 15, 2025 |
| Vancomycin Hydrochloride | 39822-0460 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 15, 2025 |
| Olanzapine | 39822-1800 | Injection, powder, for solution | Generic drugs (ANDA) | August 28, 2025 |
| Dehydrated Alcohol | 39822-9300 | Injection, solution | Generic drugs (ANDA) | June 24, 2025 |
| Nelarabine | 39822-0650 | Injection | Generic drugs (ANDA) | February 17, 2025 |
| Desmopressin Acetate | 39822-6250 | Injection, solution | Generic drugs (ANDA) | March 22, 2024 |
| Desmopressin Acetate | 39822-6200 | Injection, solution | Generic drugs (ANDA) | March 22, 2024 |
| Cyclophosphamide | 39822-0260 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 19, 2023 |
| Cyclophosphamide | 39822-0255 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 19, 2023 |
| Cyclophosphamide | 39822-0250 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 19, 2023 |
| Pentamidine Isethionate | 39822-3030 | Inhalant | Generic drugs (ANDA) | April 4, 2023 |
| Folic Acid | 39822-1100 | Injection, solution | Generic drugs (ANDA) | November 17, 2019 |
| Dactinomycin | 39822-2100 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | July 31, 2019 |
| Ibuprofen Lysine | 39822-1030 | Solution | Generic drugs (ANDA) | April 8, 2016 |
| Lincomycin | 39822-0353 | Injection, solution | Generic drugs (ANDA) | July 5, 2015 |
| Lincomycin | 39822-0350 | Injection, solution | Generic drugs (ANDA) | July 5, 2015 |
| Promethazine hydrochloride | 39822-5550 | Injection, solution | Generic drugs (ANDA) | January 30, 2015 |
| Promethazine hydrochloride | 39822-5525 | Injection, solution | Generic drugs (ANDA) | January 30, 2015 |
| Clonidine | 39822-2010 | Injection, solution | Generic drugs (ANDA) | October 29, 2013 |
| Clonidine | 39822-2000 | Injection, solution | Generic drugs (ANDA) | October 29, 2013 |
| Rocuronium bromide | 39822-4200 | Solution | Generic drugs (ANDA) | December 1, 2012 |
| Tranexamic Acid | 39822-1000 | Injection, solution | Generic drugs (ANDA) | May 18, 2012 |
| Levetiracetam | 39822-4000 | Injection, solution, concentrate | Generic drugs (ANDA) | August 5, 2011 |
| Acetazolamide | 39822-0190 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 10, 2008 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.